AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Cephalexin Monohydrate Equivalent To

11 registrations across 1 African market— 3 active

Markets with Cephalexin Monohydrate Equivalent To

Recent registrations

Brand / ProductMarketHolderStatusExpires
KEFLEX 250 P🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2024
LENOCEF - 125 SUSPENSION🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
LENOCEF-250 SUSPENSION🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
KEFLEX 500🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
KEFLEX 125 P🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
ASPEN-CEPHALEXIN 250P🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
LENOCEF-500🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
ASPEN-CEPHALEXIN 125P🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
RANCEPH 250 CAPSULES🇿🇦South AfricaRanbaxy (SA) (Pty) LtdactiveJan 1900
CEPHALEXIN 500 PHARMA Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900
CEPHALEXIN DRY SYRUP PHARMA-Q🇿🇦South AfricaPharma-Q Holdings (Pty) LtdactiveJan 1900

Cephalexin Monohydrate Equivalent To in Africa — Regulatory Overview

Cephalexin Monohydrate Equivalent To is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 3 (27%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.